# PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES FOR MEDICATIONS DEVELOPMENT. POP: 9/20/2017-9/19/2022. N01DA-17-8935.

> **NIH NIH N01** · ALTASCIENCES CLINICAL KANSAS INC · 2020 · $1,357,821

## Abstract

Contractor shall carry out clinical pharmacology/pharmacokinetic studies to support the development of new medications for the treatment of disorders stemming from tobacco, cannabis, cocaine, methamphetamine, or opiate use or abuse. The study medications include new molecular entities, new biological products (monoclonal antibodies, enzymes, vaccines, etc.), new drug products, and drug products approved by the Food and Drug Administration (FDA) for other indications.

## Key facts

- **NIH application ID:** 10285120
- **Project number:** 271201700056C-P00003-9999-3
- **Recipient organization:** ALTASCIENCES CLINICAL KANSAS INC
- **Principal Investigator:** DEBRA KELSH
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $1,357,821
- **Award type:** —
- **Project period:** 2017-09-20 → 2022-09-19

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10285120

## Citation

> US National Institutes of Health, RePORTER application 10285120, PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES FOR MEDICATIONS DEVELOPMENT. POP: 9/20/2017-9/19/2022. N01DA-17-8935. (271201700056C-P00003-9999-3). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10285120. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*